Individuals who use substances are at high risk for suicide and suicide attempts. In fact, substance use disorder is documented as an important risk factor for suicidality (SUDs; Poorolajal et al., 2016; Armoon et al., 2021), including among adolescents (e.g., Kelly et al., 2004). However, fewer studies have examined substance use at varying levels of severity. Further, some researchers have documented a bidirectional relationship between these variables among adolescents and young adults, where substance use influences suicidality and suicidality influences substance use, with differences by particular substance (Zhang & Wu, 2014). Yet, few studies have leveraged nationally-representative clinical datasets encompassing both outpatient and inpatient encounters to comprehensively examine this complex relationship.
Despite a growing body of literature on substance use and suicide among adolescent, a significant gap remains. Previous studies have explored the variations in the relationships between substance use and suicide mortality among different racial and ethnic groups (e.g., Karch et al., 2006; Garlow, 2002). However, a systematic investigation of disparities in clinical visits related to suicidality/self-harm involving substance use, as well as substance-related clinical visits linked to suicidality/self-harm, based on race/ethnicity, is lacking. Understanding these disparities is crucial for tailoring interventions and addressing health inequities among adolescents engaged in substance use and/or experiencing suicidality.
The importance of using nationally-representative clinical data to examine more nuanced suicide outcomes among adolescents cannot be overstated; clinical data allows for a comprehensive examination of suicidal behaviors (including ideation, attempts, and self-harm incidents) as well as substance use behaviors (use, dependence, overdose; differences by substance type), all within the context of the larger medical history.
– Aim 1: Determine how frequently visits for suicidality/self-harm events involve substance use (including comorbid visit diagnosis or attempt/self-harm by ingestion)?
– Aim 2: Examine the odds that visits related to suicidality, suicide attempts, or self-harm events involving substance use are linked to prior or subsequent visit related to substance use?
– Aim 3: Explore differences in frequency of comorbid suicidality/self-harm and substance use visits and differences in odds of a substance-related visit before or after suicidality/self-harm visit by race/ethnicity.
